Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Adoption Although the pilot program was deemed a success, the screening rate was lower than expected in comparison to other cancer screening programs, even after taking into account the impact of the COVID-19 pandemic (37)
What if now was the right time
Proteomics-antibody microarray analyses Proteomic analysis of trachea lysates using antibody microarray technology was performed whereby signaling proteins and phosphorylation sites were screened using 800 pan- and phospho-site specific antibodies with lysates from control and cigarette smoke exposed tracheal tissues (Supplemental Table 1: online only)
Master Settlement Agreement On November 16, 1998, 46 State attorneys general and the major cigarette/smokeless tobacco product manufacturers signed a Master Settlement Agreement (MSA) to reimburse States for the cost of treating smoking-related illnesses
US$ 27.54
US$ 23.50
US$ 25.86
US$ 21.57
US$ 21.20
US$ 28.78
US$ 23.91
US$ 27.98
US$ 27.57